⌘K
Loading ticker…
As of 2026-08-24, RxSight, Inc. Common Stock (RXST) has a 3-month relative strength percentile of 54 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.2%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
RXST is held by 13 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $3M.
Held by 24 ETFs · $23M across latest filings · largest weight 0.63% (FFOX).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $927K | — |
| VHTVanguard Health Care ETF | 0.00% | $553K | — |
| VTWG | 0.01% | $194K | — |
| AVSC | 0.01% | $158K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $112K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $16K | — |
| ITWO | 0.01% | $10K | — |
| MSSM | 0.00% | $9K | — |
| URTY | 0.00% | $8K | — |
Showing 10 of 13 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RXST Jan avg: 1.32% median: 4.51% win: 50% σ: 13.50% n: 4 2022-04-12 → 2026-07-31 | RXST Feb avg: -3.07% median: -7.96% win: 25% σ: 16.54% n: 4 2022-04-12 → 2026-07-31 | RXST Mar avg: -3.13% median: -8.22% win: 25% σ: 17.20% n: 4 2022-04-12 → 2026-07-31 | RXST Apr avg: -3.89% median: 1.07% win: 60% σ: 22.01% n: 5 2022-04-12 → 2026-07-31 | RXST May avg: 7.78% median: 11.33% win: 80% σ: 21.80% n: 5 2022-04-12 → 2026-07-31 | RXST Jun avg: -0.08% median: 2.91% win: 60% σ: 12.89% n: 5 2022-04-12 → 2026-07-31 | RXST Jul avg: -3.46% median: 6.25% win: 60% σ: 27.50% n: 5 2022-04-12 → 2026-07-31 | RXST Aug avg: 2.49% median: 1.57% win: 50% σ: 20.12% n: 4 2022-04-12 → 2026-07-31 (current) | RXST Sep avg: -5.21% median: -3.97% win: 0% σ: 5.02% n: 4 2022-04-12 → 2026-07-31 | RXST Oct avg: -4.17% median: 0.13% win: 50% σ: 11.25% n: 4 2022-04-12 → 2026-07-31 | RXST Nov avg: 15.33% median: 16.29% win: 75% σ: 21.05% n: 4 2022-04-12 → 2026-07-31 | RXST Dec avg: -0.63% median: -4.77% win: 25% σ: 25.31% n: 4 2022-04-12 → 2026-07-31 |